COVID-19 Therapeutics: Resources for Health Care Professionals and Public Health Officials

New and Notable: COVID-19 Therapeutics Announcements

April 14, 2023: HHS Announces Intent to Amend the Declaration Under the PREP Act for Medical Countermeasures Against COVID-19
April 14, 2023: Letter to U.S. Governors from HHS Secretary Xavier Becerra on renewing COVID-19 Public Health Emergency (PHE)
April 7, 2023: Now Available! Searchable COVID-19 Therapeutic Product Shelf-Life Expiration Dates Database
March 2, 2023: COVID-19 and the PREP Act: Frequently Asked Questions
March 1, 2023: COVID-19 Medical Countermeasures Commercialization: Frequently Asked Questions

COVID-19 therapeutics can be used to prevent or treat eligible non-hospitalized patients who have mild to moderate COVID-19 symptoms. Prevention and early treatment for eligible patients can help improve patient outcomes, reduce stress on healthcare facilities, and even save lives.

HHS/ASPR has purchased supplies of COVID-19 therapeutic products and we are working with state and territorial health departments as well as national healthcare and medical organizations and associations to get the treatments into the hands of healthcare providers quickly, with a focus on areas of the country hardest hit by the pandemic.